Theriva Biologics, Inc. Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months
Theriva Biologics, Inc. (TOVX) had Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months of $34.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Long-Term Debt, Rolling Maturity
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths · last filed 2026-08-11
- 2026-06-30: Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months $34.00K.
- 2026-03-31: Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months $8.00K.
- 2025-12-31: Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months $57.00K.
- 2025-09-30: Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months $57.00K.
| Period end | Long-term Debt, Maturities, Repayments of Principal in Next Rolling Twelve Months |
|---|---|
| 2026-06-30 | $34.00K 10-Q · filed 2026-08-11 |
| 2026-03-31 | $8.00K 10-Q · filed 2026-05-05 |
| 2025-12-31 | $57.00K 10-K · filed 2026-03-12 |
| 2025-09-30 | $57.00K 10-Q · filed 2025-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |